0.2763
4.61%
-0.0121
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BNGO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.2884
Offen:
$0.2999
24-Stunden-Volumen:
4.50M
Relative Volume:
1.12
Marktkapitalisierung:
$29.41M
Einnahmen:
$36.12M
Nettoeinkommen (Verlust:
$-232.49M
KGV:
-0.0173
EPS:
-16.0015
Netto-Cashflow:
$-126.87M
1W Leistung:
+27.36%
1M Leistung:
+8.18%
6M Leistung:
-51.75%
1J Leistung:
-86.24%
Bionano Genomics Inc Stock (BNGO) Company Profile
Firmenname
Bionano Genomics Inc
Sektor
Telefon
(858) 888-7600
Adresse
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Vergleichen Sie BNGO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
0.2755 | 29.41M | 36.12M | -232.49M | -126.87M | -17.78 |
ISRG
Intuitive Surgical Inc
|
525.72 | 185.91B | 7.87B | 2.24B | 586.00M | 6.22 |
BDX
Becton Dickinson Co
|
228.64 | 65.79B | 20.18B | 1.71B | 3.07B | 5.94 |
ALC
Alcon Inc
|
84.39 | 41.99B | 9.76B | 1.16B | 665.00M | 2.34 |
RMD
Resmed Inc
|
229.60 | 33.57B | 4.81B | 1.11B | 1.35B | 7.55 |
WST
West Pharmaceutical Services Inc
|
331.29 | 23.72B | 2.88B | 499.60M | 321.60M | 6.74 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-11-15 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
2024-09-10 | Herabstufung | BTIG Research | Buy → Neutral |
2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
2022-12-12 | Fortgesetzt | BTIG Research | Buy |
2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
2021-06-16 | Eingeleitet | BTIG Research | Buy |
2020-09-24 | Eingeleitet | Ladenburg Thalmann | Buy |
2020-04-08 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Bionano Genomics Inc Aktie (BNGO) Neueste Nachrichten
S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail
Nasdaq Biotechnology Index (NBI) QuotePress Release - The Globe and Mail
Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway - The Manila Times
Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway - GlobeNewswire Inc.
Senior Loan Invesco ETF (BKLN-A) QuotePress Release - The Globe and Mail
Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis - The Manila Times
Bionano's Groundbreaking Study: Optical Genome Mapping Achieves 100% Detection Rate in Cancer Analysis - StockTitan
Bionano Genomics stock hits 52-week low at $0.2 amid market challenges - Investing.com India
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal - The Manila Times
Bionano Genomics Issues Critical Stockholder Letter Ahead of Special Meeting - StockTitan
Bionano Genomics, Inc. (NASDAQ:BNGO) Might Not Be As Mispriced As It Looks - Simply Wall St
Uber Technologies Inc (UBER-N) QuotePress Release - The Globe and Mail
Bionano Genomics announces presentations at ASH annual meeting - Nasdaq
Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy - The Manila Times
Bionano Genomics Showcases Breakthrough OGM Technology Across 13 Cancer Research Studies at ASH 2024 - StockTitan
Tractor Supply Company (TSCO-Q) QuotePress Release - The Globe and Mail
Bionano Genomics (STU:2Y30) Current Ratio : 1.43 (As of Sep. 2024) - GuruFocus.com
Bionano Genomics shareholders approve warrant share issuance By Investing.com - Investing.com Nigeria
Bionano Genomics shareholders approve warrant share issuance - Investing.com
Bionano Genomics (LTS:0A4K) Enterprise Value : $25.57 Mil (As of Dec. 01, 2024) - GuruFocus.com
Bionano Genomics (LTS:0A4K) Degree of Operating Leverage : 51.41 (As of Sep. 2024) - GuruFocus.com
Bionano Genomics (FRA:2Y30) Current Ratio : 1.43 (As of Sep. 2024) - GuruFocus.com
Bionano Genomics stock hits 52-week low at $0.2 By Investing.com - Investing.com Australia
Bionano Genomics stock hits 52-week low at $0.2 - Investing.com
BNGO (Bionano Genomics) Accumulated other comprehensive inc - GuruFocus.com
BNGO (Bionano Genomics) 50-Day SMA : $0.35 (As of Nov. 20, 2024) - GuruFocus.com
BNGO (Bionano Genomics) 6-Month Price Index : 0.20 (As of Nov. 20, 2024) - GuruFocus.com
Bionano Genomics (FRA:2Y30) Operating Margin % : -372.57% (As of Sep. 2024) - GuruFocus.com
BTIG maintains neutral on BNGO shares amid Q3 results and strategy shift - Investing.com
Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2024 Earnings Call Transcript - Insider Monkey
Bionano Genomics Inc (BNGO) Quarterly 10-Q Report - Quartzy
Bionano Genomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Bionano Genomics stock hits 52-week low at $0.26 By Investing.com - Investing.com Australia
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress - The Manila Times
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: St - GuruFocus.com
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... By GuruFocus - Investing.com Canada
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... - Yahoo Finance
Optical Genome Mapping Market Size, Share, Trends, - openPR
Bionano Genomics Sees Growth in OGM Adoption - TipRanks
Earnings call: Bionano reports Q3 revenue dip, shifts focus to efficiency - Investing.com Canada
Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript - MSN
Bionano Genomics Q3 Revenue Falls 35% Despite OGM System Growth; Reports Mixed Results | BNGO Stock News - StockTitan
Bionano Genomics stock hits 52-week low at $0.26 - Investing.com
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024 - Barchart
Earnings Outlook For Bionano Genomics - Benzinga
U.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 0.67% - Investing.com
Asia stocks fall as China stimulus disappoints, deflation persists - Investing.com
XRP Climbs 10.07% In Bullish Trade - Investing.com UK
Bionano Genomics Inc (BNGO): Major Improvements, Worth A Look - Stocks Register
Bionano Genomics (BNGO) Sets Q3 2024 Earnings Call for November 13 | BNGO Stock News - StockTitan
Optical Genome Mapping Market to Witness 26.76% CAGR During - GlobeNewswire
Finanzdaten der Bionano Genomics Inc-Aktie (BNGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):